Share on StockTwits

Span-America Medical (NASDAQ:SPAN) Director Thomas D. Henrion unloaded 2,600 shares of Span-America Medical stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $18.96, for a total value of $49,296.00. Following the completion of the sale, the director now directly owns 127,084 shares of the company’s stock, valued at approximately $2,409,513. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Separately, analysts at Sidoti downgraded shares of Span-America Medical from a “buy” rating to a “neutral” rating in a research note on Wednesday, August 6th.

Span-America Medical (NASDAQ:SPAN) traded up 0.78% during mid-day trading on Thursday, hitting $19.45. 12,747 shares of the company’s stock traded hands. Span-America Medical has a 52 week low of $18.09 and a 52 week high of $25.02. The stock has a 50-day moving average of $19. and a 200-day moving average of $20.78. The company has a market cap of $57.6 million and a price-to-earnings ratio of 18.21.

Span-America Medical (NASDAQ:SPAN) last issued its quarterly earnings data on Monday, August 4th. The company reported $0.13 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.34 by $0.21. The company had revenue of $13.30 billion for the quarter, compared to the consensus estimate of $18.62 billion. Analysts expect that Span-America Medical will post $0.86 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Thursday, September 4th. Stockholders of record on Thursday, August 14th will be given a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 3.11%. The ex-dividend date of this dividend is Tuesday, August 12th. This is a boost from Span-America Medical’s previous quarterly dividend of $0.14.

Span-America Medical Systems, Inc manufactures and distributes a variety of therapeutic support surfaces and related products utilizing polyurethane and other foam products for the medical, consumer and industrial markets.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.